Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck
- Lars Bastholt
- , Lena Specht
- , Kenneth Jensen
- , Eva Brun
- , Annika Loft
- , Jørgen Petersen
- , Helle Kastberg
- , Jesper G Eriksen
Research output: Contribution to journal › Journal article › Research › peer-review